PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The validations confirm the completion of the applications and commence the scientific review process
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
ANVISA issues CGMP to Concord Biotech’s Unit I
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
This agreement paves the way for the introduction of YESAFILI into the Canadian market
Subscribe To Our Newsletter & Stay Updated
